A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

Summary

The purpose of this research study is to examine if a combination of a cholesterol lowering-drug, simvastatin, with a sugar-lowering drug called rosiglitazone is more effective in improving vascular inflammation (irritation of the vessels that transport your blood) and other cardiovascular risk factors than the taking of simvastatin alone.

Timeline

Start

2006-09

Primary completion

2011-03

Completion

2011-04

Drugs

Indications